Physalis angulata L. antineoplasic activity, in vitro, evaluation fromit's stems and fruit capsules

In Vitro Determination of Antioxidant Activity of Physalis Angulata Lnn

The present investigation was carried out to determine the antioxidant properties in methanolic extract of leaves, stem, fruit and roots of Physalis angulata (L). The antioxidant assay was carried out using free radicals DPPH, superoxide, nitric oxide, hydrogen peroxide and hydroxyl radical. Among the extracts tested fruit and leaf extracts were found to be significant in their antioxidant prop...

Physalis Angulata L . : an Ethanopharmacological Review

Genotoxic effect of Physalis angulata L. (Solanaceae) extract on human lymphocytes treated in vitro.

Physalis angulata L (Solanaceae) is a medicinal plant from North of Brazil, whose different extracts and infusions are commonly used in the popular medicine for the treatment of malaria, asthma, hepatitis, dermatitis and rheumatism. However, the genotoxic effects of P. angulata on human cells is not well known. The main purpose of the present study was to evaluate the in vitro genotoxic effects...

Intestinal anti-inflammatory activity of Ground Cherry (Physalis angulata L.) standardized CO2 phytopharmaceutical preparation

AIM To investigate the effects of Ground Cherry (Physalis angulata L.) standardized supercritical CO2 extract in trinitrobenzenesulphonic acid (TNBS) model of rat intestinal inflammation. METHODS The animals were divided into groups that received vehicle or P. angulata extract (PACO2) orally at the doses 25, 50 and 100 mg/kg daily by 5 d before TNBS damage. Protective effects of PACO2 were as...

Genotoxicity and antileishmanial activity evaluation of Physalis angulata concentrated ethanolic extract.

UNLABELLED Antileishmanial in vitro tests, as well as Ames and micronucleus assays were performed with a concentrated ethanolic extract of Physalis angulata (EEPA) RESULTS: EEPA did not present mutagenic effect in Salmonella typhimurium strains at concentration reaching 3000 μg/plate and did not induce mutagenic effects after two oral administrations with a 24h interval at a dose level of 2000 ...